Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: Long-term results of the UNICANCER ACCORD 16 phase II trial
2015 ◽
Vol 114
(3)
◽
pp. 415-416
◽
Keyword(s):
Phase Ii
◽